The stock of Haoxi Health Technology Ltd (HAO) has gone down by -23.93% for the week, with a -11.85% drop in the past month and a -46.56% drop in the past quarter. The volatility ratio for the week is 13.91%, and the volatility levels for the past 30 days are 15.39% for HAO. The simple moving average for the past 20 days is -24.31% for HAO’s stock, with a -96.56% simple moving average for the past 200 days.
Is It Worth Investing in Haoxi Health Technology Ltd (NASDAQ: HAO) Right Now?
The price-to-earnings ratio for Haoxi Health Technology Ltd (NASDAQ: HAO) is above average at 2.78x, Company’s 36-month beta value is -2.82.
The public float for HAO is 16.53M, and currently, short sellers hold a 3.38% ratio of that floaft. The average trading volume of HAO on January 23, 2025 was 7.93M shares.
HAO) stock’s latest price update
Haoxi Health Technology Ltd (NASDAQ: HAO) has experienced a decline in its stock price by -22.07 compared to its previous closing price of 0.13. However, the company has seen a fall of -23.93% in its stock price over the last five trading days. globenewswire.com reported 2025-01-23 that BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) — Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it has resolved to effect a reverse share split of the Company’s ordinary shares, with the split ratio set at 1-for-25 (the “Reverse Share Split”). The Reverse Share Split was approved by the Company’s shareholders at an annual general meeting of shareholders held on January 10, 2025. The Company’s Class A ordinary shares will begin trading on an adjusted basis on the Nasdaq Capital Market, reflecting the Reverse Share Split, when the market opens on January 27, 2025, under the existing ticker symbol “HAO.” The new CUSIP number for the Company’s Class A ordinary shares will be G4290F118.
HAO Trading at -32.76% from the 50-Day Moving Average
After a stumble in the market that brought HAO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.01% of loss for the given period.
Volatility was left at 15.39%, however, over the last 30 days, the volatility rate increased by 13.91%, as shares surge +5.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.89% lower at present.
During the last 5 trading sessions, HAO fell by -23.86%, which changed the moving average for the period of 200-days by -97.68% in comparison to the 20-day moving average, which settled at $0.1386. In addition, Haoxi Health Technology Ltd saw -30.07% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HAO
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.06 for the gross margin
The net margin for Haoxi Health Technology Ltd stands at 0.03. The total capital return value is set at 0.2.
Based on Haoxi Health Technology Ltd (HAO), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -0.62. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is 70.49.
Currently, EBITDA for the company is 1.79 million with net debt to EBITDA at -2.08. When we switch over and look at the enterprise to sales, we see a ratio of -0.03. The receivables turnover for the company is 13.67for trailing twelve months and the total asset turnover is 3.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.98.
Conclusion
In a nutshell, Haoxi Health Technology Ltd (HAO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
